OBJECTIVES: This paper discusses the development of a minimal dataset (MDS) for tobacco cessation quitlines across North America. The goal was to create a standardised instrument and protocol that would allow for comparisons and pooling of data across quitlines for evaluation and research purposes. Principles of utilisation focused evaluation were followed to achieve consensus across diverse stakeholder groups in two countries. METHODS: The North American Quitline Consortium (NAQC) assembled a working group with representatives from quitline service providers, funders, evaluators and researchers from Canada and the United States. An extensive, iterative consultation process over two years led to consensus on the evaluation domains, indicators and specific items. Descriptive information on quitline service models, data collection protocols and methodological issues were addressed. RESULTS: The resulting minimal dataset (MDS) includes 15 items collected from eligible callers at intake and eight items collected from smokers participating in evaluation. Recommendations for selecting evaluation participants, length of follow-up and repeat callers were developed. Full MDS questions and technical documents are available on the NAQC website. CONCLUSION: Adoption and implementation of the MDS occurred in the majority of North American quitlines by the end of 2006. Key success factors included a focus on utility and feasibility, a commitment to meeting multiple and varied needs, sensitivity to situational factors and investment in working interactively with stakeholders. The creation and implementation of a MDS across two countries is an important "first" in tobacco control which will help speed the creation of practice based evidence and facilitate practice based research.
OBJECTIVES: This paper discusses the development of a minimal dataset (MDS) for tobacco cessation quitlines across North America. The goal was to create a standardised instrument and protocol that would allow for comparisons and pooling of data across quitlines for evaluation and research purposes. Principles of utilisation focused evaluation were followed to achieve consensus across diverse stakeholder groups in two countries. METHODS: The North American Quitline Consortium (NAQC) assembled a working group with representatives from quitline service providers, funders, evaluators and researchers from Canada and the United States. An extensive, iterative consultation process over two years led to consensus on the evaluation domains, indicators and specific items. Descriptive information on quitline service models, data collection protocols and methodological issues were addressed. RESULTS: The resulting minimal dataset (MDS) includes 15 items collected from eligible callers at intake and eight items collected from smokers participating in evaluation. Recommendations for selecting evaluation participants, length of follow-up and repeat callers were developed. Full MDS questions and technical documents are available on the NAQC website. CONCLUSION: Adoption and implementation of the MDS occurred in the majority of North American quitlines by the end of 2006. Key success factors included a focus on utility and feasibility, a commitment to meeting multiple and varied needs, sensitivity to situational factors and investment in working interactively with stakeholders. The creation and implementation of a MDS across two countries is an important "first" in tobacco control which will help speed the creation of practice based evidence and facilitate practice based research.
Authors: Shu-Hong Zhu; Christopher M Anderson; Gary J Tedeschi; Bradley Rosbrook; Cynthia E Johnson; Michael Byrd; Elsa Gutiérrez-Terrell Journal: N Engl J Med Date: 2002-10-03 Impact factor: 91.245
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Asgeir R Helgason; Tanja Tomson; Karl E Lund; Rosaria Galanti; Staffan Ahnve; Hans Gilljam Journal: Eur J Public Health Date: 2004-09 Impact factor: 3.367
Authors: Julie E Maher; Kristen Rohde; Clyde W Dent; Michael J Stark; Barbara Pizacani; Michael J Boysun; Julia A Dilley; Patricia L Yepassis-Zembrou Journal: Tob Control Date: 2007-12 Impact factor: 7.552
Authors: N Bruce Baskerville; K Stephen Brown; Nghia C Nguyen; Lynda Hayward; Ryan David Kennedy; David Hammond; H Sharon Campbell Journal: CMAJ Open Date: 2016-02-17
Authors: H Sharon Campbell; N Bruce Baskerville; Lynda M Hayward; K Stephen Brown; Deborah J Ossip Journal: Nicotine Tob Res Date: 2013-12-05 Impact factor: 4.244
Authors: Kara L Hall; Brooke A Stipelman; Katherine S Eddens; Matthew W Kreuter; Sherry I Bame; Helen I Meissner; K Robin Yabroff; Jason Q Purnell; Rebecca Ferrer; Kurt M Ribisl; Russell Glasgow; Laura A Linnan; Stephen Taplin; Maria E Fernández Journal: Am J Prev Med Date: 2012-12 Impact factor: 5.043
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Michael A Zevon; Robert Reed; Pat Hysert; Martin C Mahoney; Andrew J Hyland; Chukwumere Nwogu; Todd Demmy; Elisabeth Dexter; Maureen Kelly; Richard J O'Connor; Teresa Houstin; Dana Jenkins; Pamela Germain; Anurag K Singh; Jennifer Epstein; Katharine A Dobson Amato; Mary E Reid Journal: Cancer Date: 2013-10-25 Impact factor: 6.860